These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36253533)

  • 1. Proband-mediated interventions to increase disclosure of genetic risk in families with a BRCA or Lynch syndrome condition: a systematic review.
    Young AL; Imran A; Spoelma MJ; Williams R; Tucker KM; Halliday J; Forrest LE; Wakefield CE; Butow PN
    Eur J Hum Genet; 2023 Jan; 31(1):18-34. PubMed ID: 36253533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct letters to relatives at risk of hereditary cancer-study protocol for a multi-center randomized controlled trial of healthcare-assisted versus family-mediated risk disclosure at Swedish cancer genetics clinics (DIRECT-study).
    Hawranek C; Ehrencrona H; Öfverholm A; Hellquist BN; Rosén A
    Trials; 2023 Dec; 24(1):810. PubMed ID: 38105176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice.
    Menko FH; Ter Stege JA; van der Kolk LE; Jeanson KN; Schats W; Moha DA; Bleiker EMA
    Fam Cancer; 2019 Jan; 18(1):127-135. PubMed ID: 29846880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of genetic testing by relatives of lynch syndrome probands: a systematic review.
    Sharaf RN; Myer P; Stave CD; Diamond LC; Ladabaum U
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1093-100. PubMed ID: 23669308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sharing genetic test results in Lynch syndrome: communication with close and distant relatives.
    Stoffel EM; Ford B; Mercado RC; Punglia D; Kohlmann W; Conrad P; Blanco A; Shannon KM; Powell M; Gruber SB; Terdiman J; Chung DC; Syngal S
    Clin Gastroenterol Hepatol; 2008 Mar; 6(3):333-8. PubMed ID: 18258490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA testing.
    Aktan-Collan K; Haukkala A; Pylvänäinen K; Järvinen HJ; Aaltonen LA; Peltomäki P; Rantanen E; Kääriäinen H; Mecklin JP
    J Med Genet; 2007 Nov; 44(11):732-8. PubMed ID: 17630403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests.
    Pujol P; Lyonnet DS; Frebourg T; Blin J; Picot MC; Lasset C; Dugast C; Berthet P; de Paillerets BB; Sobol H; Grandjouan S; Soubrier F; Buecher B; Guimbaud R; Lidereau R; Jonveaux P; Houdayer C; Giraud S; Olschwang S; Nogue E; Galibert V; Bara C; Nowak F; Khayat D; Nogues C
    Breast Cancer Res Treat; 2013 Aug; 141(1):135-44. PubMed ID: 23974829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving family communication after a new genetic diagnosis: a randomised controlled trial of a genetic counselling intervention.
    Hodgson JM; Metcalfe SA; Aitken M; Donath SM; Gaff CL; Winship IM; Delatycki MB; Skene LL; McClaren BJ; Paul JL; Halliday JL
    BMC Med Genet; 2014 Mar; 15():33. PubMed ID: 24628824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The experience of receiving a letter from a cancer genetics clinic about risk for hereditary cancer.
    Öfverholm A; Karlsson P; Rosén A
    Eur J Hum Genet; 2024 May; 32(5):539-544. PubMed ID: 38355958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When to break the news and whose responsibility is it? A cross-sectional qualitative study of health professionals' views regarding disclosure of BRCA genetic cancer risk.
    Young AL; Butow PN; Tucker KM; Wakefield CE; Healey E; Williams R
    BMJ Open; 2020 Feb; 10(2):e033127. PubMed ID: 32102811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How families communicate about HNPCC genetic testing: findings from a qualitative study.
    Peterson SK; Watts BG; Koehly LM; Vernon SW; Baile WF; Kohlmann WK; Gritz ER
    Am J Med Genet C Semin Med Genet; 2003 May; 119C(1):78-86. PubMed ID: 12704641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experience.
    Wagner Costalas J; Itzen M; Malick J; Babb JS; Bove B; Godwin AK; Daly MB
    Am J Med Genet C Semin Med Genet; 2003 May; 119C(1):11-8. PubMed ID: 12704633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparing individuals to communicate genetic test results to their relatives: report of a randomized control trial.
    Montgomery SV; Barsevick AM; Egleston BL; Bingler R; Ruth K; Miller SM; Malick J; Cescon TP; Daly MB
    Fam Cancer; 2013 Sep; 12(3):537-46. PubMed ID: 23420550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the utilization of educational materials in communicating about Lynch syndrome to at-risk relatives.
    Dilzell K; Kingham K; Ormond K; Ladabaum U
    Fam Cancer; 2014 Sep; 13(3):381-9. PubMed ID: 24770865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The introduction of a choice to learn pre-symptomatic DNA test results for BRCA or Lynch syndrome either face-to-face or by letter.
    Voorwinden JS; Jaspers JP; ter Beest JG; Kievit Y; Sijmons RH; Oosterwijk JC
    Clin Genet; 2012 May; 81(5):421-9. PubMed ID: 22091929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
    Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients' perceptions and practices of informing relatives: a qualitative study within a randomised trial on healthcare-assisted risk disclosure.
    Nääs C; von Salomé J; Rosén A
    Eur J Hum Genet; 2024 Apr; 32(4):448-455. PubMed ID: 38308085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to inform relatives at risk of hereditary diseases? A mixed-methods systematic review on patient attitudes.
    van den Heuvel LM; Smets EMA; van Tintelen JP; Christiaans I
    J Genet Couns; 2019 Oct; 28(5):1042-1058. PubMed ID: 31216099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Follow-Up Study on the Uptake of Genetic Counseling and Predictive DNA Testing in Inherited Cardiac Conditions.
    van den Heuvel LM; van Teijlingen MO; van der Roest W; van Langen IM; Smets EMA; van Tintelen JP; Christiaans I
    Circ Genom Precis Med; 2020 Oct; 13(5):524-530. PubMed ID: 33079600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facilitating family communication about predictive genetic testing: probands' perceptions.
    Gaff CL; Collins V; Symes T; Halliday J
    J Genet Couns; 2005 Apr; 14(2):133-40. PubMed ID: 15959644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.